Back to search

Article

Financial Feasibility Study and policy recommendations of Incremental Modified Drugs Development by the Domestic Pharmaceutical Industry

2024-07-29

Abstract excerpt

The Thai pharmaceutical industry aims to strengthen its drug system in accordance with the National Strategic Master Plan, emphasizing sustainable development, particularly in biologics and herbal products, to achieve self-reliance. Current efforts are mainly focused on generic drug production, but there’s a significant need for Research and Development (R&D) in Innovative Medicines (IMDs). This study explores the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bd042992-ff7b-5295-a730-e8e3a4d476b6
DOI
10.1101/2024.07.29.24311184
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Financial Feasibility Study and policy recommendations of Incremental Modified Drugs Development by the Domestic Pharmaceutical IndustryDOI 10.1101/2024.07.29.24311184
Non-commercial pharmaceutical R&D: what do neglected diseases suggest about costs and efficiency?Semantic proximity
Measuring the Impact of Global R&D Investment in Product Development Partnerships (PDPs): A Case Study on Return on Investment in Antimalarial Drug DevelopmentSemantic proximity
Assessing the Value of Integrated Evidence Approaches in Drug DevelopmentSemantic proximity
Pharmaceutical Drug Lifecycle: A Comprehensive Scientific Review of Research and Development Phases, Attrition Rates, and Global DisparitiesSemantic proximity
Differences in the cost of manufacturing pharmaceuticals in India for differently regulated markets: A comparative analysisSemantic proximity
U.S. Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018Semantic proximity
The impact of National Centralized Drug Procurement policy on the use of policy-related original and generic drugs in public medical institutions in China: A difference-in-difference analysis based on national databaseSemantic proximity
Academic challenges on ATMPs’ development: a regulatory perspectiveSemantic proximity
The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?Semantic proximity
The Net Financial Benefits of Single Vendor Integrated CDMO and CRO Drug Development ServicesSemantic proximity
Design and rationale for an empirical investigation of the resource use and costs of investigator-initiated randomized trials in Switzerland, the United Kingdom, and GermanySemantic proximity
Opportunities, Constraints and Critical Supports for Achieving Sustainable Local Pharmaceutical Manufacturing in Africa: With a Focus on the Role of Finance, Final ReportSemantic proximity
Select a neighboring publication to make it the new centre.